These specimens undergo rigorous evaluation, encompassing blood type identification and serological and nucleic acid testing (NAT) for transfusion-transmissible infectious disease markers, in addition to alanine aminotransferase (ALT) testing [1]. The gene discussed is GPT; the disease is infectious disease.